<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02426970</url>
  </required_header>
  <id_info>
    <org_study_id>AOI/2014/AD-01</org_study_id>
    <secondary_id>2014-A01373-44</secondary_id>
    <nct_id>NCT02426970</nct_id>
  </id_info>
  <brief_title>Are Acceptance and Commitment Related to Treatment Response in Chronic Low Back Pain</brief_title>
  <acronym>COP-PAIN</acronym>
  <official_title>Are Acceptance and Commitment Related to Treatment Response in Chronic Low Back Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this study is to evaluate whether acceptance (measured by the AAQ-II
      questionnaire) is prognostic of algo-functional changes measured by the Oswestry Disability
      Index, ODI) at 6 months.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The secondary objectives are:

      A. To search for correlations between the acceptance score (AAQ-II Questionnaire) and scores
      for coping (CSQ), avoidance (FABQ), understanding (BBQ), anxiety and depression (HADS) and
      quality of life (SF-12) at baseline.

      B. To describe the kinetics of changes in various parameters (acceptance, coping, avoidance,
      understanding, anxiety and depression, quality of life, ODI) over 6 months.

      C. To evaluate the agreement between two methods of questionnaire presentation: Paper
      collection versus collection by Tablet PC.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 3, 2017</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Classification of the patient as a responder or a non responder</measure>
    <time_frame>6 months</time_frame>
    <description>The response to treatment will be evaluated by the ODI (Oswestry Disability Index) at 6 months: a patient will be considered as a responder when the absolute change between the score at 6 months and inclusion is at least 10 points (Ostelo RW et al., 2008).
This outcome is a qualitative variable with two options: responder or non-responder. The fact that we define in an apriori fashion who is a responder or not does not mean that we have created multiple outcomes. This is a single outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Acceptation and Action Questionnaire - II (AAQ-II) score</measure>
    <time_frame>Day -7 (inclusion)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>the AAQ-II Score</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the AAQ-II Score</measure>
    <time_frame>Month 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the AAQ-II Score</measure>
    <time_frame>Month 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the AAQ-II Score</measure>
    <time_frame>Month 6</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oswestry Disability Index</measure>
    <time_frame>Day -7</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oswestry Disability Index</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oswestry Disability Index</measure>
    <time_frame>Month 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oswestry Disability Index</measure>
    <time_frame>Month 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oswestry Disability Index</measure>
    <time_frame>Month 6</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Coping Strategies Questionnaire in French (CSQ-F)</measure>
    <time_frame>Day -7</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Coping Strategies Questionnaire in French (CSQ-F)</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Coping Strategies Questionnaire in French (CSQ-F)</measure>
    <time_frame>Month 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Coping Strategies Questionnaire in French (CSQ-F)</measure>
    <time_frame>Month 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Coping Strategies Questionnaire in French (CSQ-F)</measure>
    <time_frame>Month 6</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Back Beliefs Questionnaire</measure>
    <time_frame>Day -7</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Back Beliefs Questionnaire</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Back Beliefs Questionnaire</measure>
    <time_frame>Month 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Back Beliefs Questionnaire</measure>
    <time_frame>Month 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Back Beliefs Questionnaire</measure>
    <time_frame>Month 6</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Fear-Avoidance Beliefs Questionnaire</measure>
    <time_frame>Day -7</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Fear-Avoidance Beliefs Questionnaire</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Fear-Avoidance Beliefs Questionnaire</measure>
    <time_frame>Month 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Fear-Avoidance Beliefs Questionnaire</measure>
    <time_frame>Month 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Fear-Avoidance Beliefs Questionnaire</measure>
    <time_frame>Month 6</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Hospital Anxiety and Depression Scale</measure>
    <time_frame>Day -7</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Hospital Anxiety and Depression Scale</measure>
    <time_frame>Day -0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Hospital Anxiety and Depression Scale</measure>
    <time_frame>Month 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Hospital Anxiety and Depression Scale</measure>
    <time_frame>Month 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Hospital Anxiety and Depression Scale</measure>
    <time_frame>Month 6</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The SF-12 questionnaire</measure>
    <time_frame>Day -7</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The SF-12 questionnaire</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The SF-12 questionnaire</measure>
    <time_frame>Month 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The SF-12 questionnaire</measure>
    <time_frame>Month 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The SF-12 questionnaire</measure>
    <time_frame>Month 6</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average pain over the last 8 days measured via visual analog scale.</measure>
    <time_frame>Day -7</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average pain over the last 8 days measured via visual analog scale.</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average pain over the last 8 days measured via visual analog scale.</measure>
    <time_frame>Month 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average pain over the last 8 days measured via visual analog scale.</measure>
    <time_frame>Month 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average pain over the last 8 days measured via visual analog scale.</measure>
    <time_frame>Month 6</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum pain over the last 8 days measured via visual analog scale.</measure>
    <time_frame>Day -7</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum pain over the last 8 days measured via visual analog scale.</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum pain over the last 8 days measured via visual analog scale.</measure>
    <time_frame>Month 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum pain over the last 8 days measured via visual analog scale.</measure>
    <time_frame>Month 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum pain over the last 8 days measured via visual analog scale.</measure>
    <time_frame>Month 6</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Low Back Pain</condition>
  <arm_group>
    <arm_group_label>Lumbar spine pain inpatients</arm_group_label>
    <description>The study population corresponds to inpatient rehabilitative care for lumbar spine pain in the Departments of Physical Medicine and Functional Rehabilitation at the Nîmes and Montpellier University Hospitals.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The study population corresponds to inpatient rehabilitative care for lumbar spine pain in
        the Departments of Physical Medicine and Functional Rehabilitation at the Nîmes and
        Montpellier University Hospitals.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patient has been informed about the study, and is not opposed to the study

          -  The patient must be insured or beneficiary of a health insurance plan

          -  The patient is available for 6 month of follow-up

          -  The subject has chronic back pain that is not post-operative in nature and that has
             lasted for more than 3 months

          -  The subject accepts the re-education curriculum.

        Exclusion Criteria:

          -  The patient is participating in another study

          -  The patient is in an exclusion period determined by a previous study

          -  The patient is under judicial protection, under tutorship or curatorship

          -  The patient refuses to participate

          -  It is impossible to correctly inform the patient

          -  The patient is pregnant, parturient, or breastfeeding

          -  The subject has a history of chronic obstructive pulmonary disease, cardiovascular
             disease, rheumatoid arthritis, lupus, spondylitis or neoplastic disease.

          -  Patient currently under psychological treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>74 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arnaud Dupeyron, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Centre Hospitalier Universitaire de Nîmes</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Arnaud Dupeyron, MD, PhD</last_name>
    <phone>+33.(0)4.66.68.34.59</phone>
    <email>arnaud.dupeyron@chu-nimes.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Carey M Suehs, PhD</last_name>
    <phone>+33.(0)4.66.68.67.88</phone>
    <email>carey.suehs@chu-nimes.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHRU de Montpellier - Hôpital Lapeyronie</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Isabelle Tavares, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHRU de Nîmes - Hôpital Universitaire Carémeau</name>
      <address>
        <city>Nîmes Cedex 09</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Claire de Labachelerie, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Arnaud Dupeyron, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 20, 2015</study_first_submitted>
  <study_first_submitted_qc>April 22, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 27, 2015</study_first_posted>
  <last_update_submitted>June 16, 2017</last_update_submitted>
  <last_update_submitted_qc>June 16, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

